Italfarmaco S.p.A. today announced a comprehensive update on the regulatory and clinical advancements for givinostat, the ...
ENCell’s investigational drug EN001 has been granted Orphan Drug Designation by the FDA for the treatment of ...
ITF Therapeutics LLC, the U.S. affiliate of Italfarmaco, today announced the opening of the company's new U.S. headquarters in Concord, Massachusetts. The 10,000-square-foot facility located at 575 ...
Limited ("Dingdong" or the "Company") , a leading fresh grocery e-commerce company in China, with advanced supply chain capabilities, today announced its unaudited financial results for the quarter ...
43m
EN001, ENCell’s therapy under development for the treatment of Charcot-Marie-Tooth (CMT) disease, has been granted Orphan ...
News Medical on MSN13h
Study sheds light on the role of fibro-adipogenic progenitors in muscle regeneration and degenerationA recent study has shed new light on the role of fibro-adipogenic progenitors (FAPs) in muscle regeneration, fibrosis, and degeneration.
20h
The growing incidence of genetic disorders and chronic illnesses, including cancer and rare inherited conditions, is fueling the demand for advanced therapies, highlighting the need for strong ...
News Medical on MSN3h
Protein cluster discovery could lead to muscular dystrophy treatmentsA new discovery about how tiny protein clusters form in cells could pave the way for treatments for Emery-Dreifuss muscular dystrophy (EDMD), a rare genetic disorder that causes muscle weakness and ...
After winning a Study U.K. Alumni Award, columnist Shalom Lim looks back on the ups and downs of his life with Duchenne ...
Racial and ethnic minorities are underrepresented in DRCRnet DME trials, despite experiencing more severe symptoms than other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback